Inicio › Cánceres de la sangre › Illinois › Chicago
Ensayos clínicos de Cánceres de la sangre en Chicago, IL
15 estudios para Cánceres de la sangre buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
ReclutandoFase 3
- The University of Chicago ( Site 0020), Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- y 1 más
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
ReclutandoEstudio observacional
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Tempus AI, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
Reclutando
- Northwestern University Feinberg School of Medicine, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- y 2 más
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
ReclutandoFase 3
- Northwestern University, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
ReclutandoFase 1
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
ReclutandoFase 1/2
- Northwestern Memorial Hospital, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutandoFase 1
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
Reclutando
- University of Chicago Comprehensive Cancer Center, Chicago
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
ReclutandoFase 1
- Northwestern University - Feinberg School of Medicine, Chicago
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
ReclutandoEstudio observacional
- MPN Research Foundation, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
ReclutandoFase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Ensayos de Cánceres de la sangre en otras ciudades
- Houston, TX46 estudios
- New York City, NY26 estudios
- Boston, MA25 estudios
- Washington, DC19 estudios
- Baltimore, MD18 estudios
- Seattle, WA18 estudios
- Los Angeles, CA17 estudios
- Durham, NC16 estudios
- Philadelphia, PA14 estudios
- Atlanta, GA13 estudios
- Nashville, TN13 estudios
- Edison, NJ13 estudios
Otros estudios en Chicago
- Cáncer de pulmón de células no pequeñas61 estudios
- Cáncer de seno58 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer metastásico45 estudios
- Cáncer de próstata45 estudios
- Obesidad41 estudios
- Cáncer de pulmón41 estudios
- Cáncer de ovario36 estudios
- Accidente cerebrovascular34 estudios
- Cáncer del colon y del recto33 estudios
- Fallo cardíaco31 estudios
- Sobrepeso28 estudios
De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.